Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

New England Journal of Medicine

Volumn 324, Issue 19, 1991, Pages 1332-1338

  Desforges, Jane F ^a   Horsburgh, C Robert ^b  

^a Grady Memorial Hospital ^*

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; FUTUROLOGY; HUMAN; INCIDENCE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HUMAN; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION;

EID: 0025852336     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199105093241906     Document Type: Review

References (75)

1. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119:107-159
2. Horsburgh C.R. Jr., Mason U.G. III, Heifets L.B., Southwick K., LaBrecque J., Iseman M.D. Response to therapy of pulmonary Mycobacterium avium–intracellulare infection correlates with the results of in vitro susceptibility testing. Am Rev Respir Dis 1987; 135:418-421
3. Tsukamura M. Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex. Am Rev Respir Dis 1988; 137:144-8
4. Davidson P.T., Khanijo V., Goble M., Moulding T.S. Treatment of disease due to Mycobacterium intracellulare. Rev Infect Dis 1981; 3:1052-9
5. Horsburgh C.R. Jr., Mason U.G. III, Farhi D.C., Iseman M.D. Disseminated infection with Mycobacterium avium–intracellulare. Medicine (Baltimore) 1985; 64:36-48
6. Young L.S., Inderlied C.B., Berlin O.G., Gottlieb M.S. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis 1986; 8:1024-33
7. Demopulos P., Sande M.A., Bryant C., Wofsy C., Brodie H., Hopewell P. Influence of Mycobacterium avium–intracellulare (MAI) infection on morbidity and survival in patients with Pneumocystis carinii pneumonia (PCP) and the acquired immunodeficiency syndrome (AIDS). In: Program and abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis, September 29—October 2, 1985. Washington, D.C.: American Society for Microbiology, 1985: 230.
8. Horsburgh C.R. Jr., Selik R.M. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1989; 139:4-7
9. Hawkins C.C., Gold J.W.M., Whimbey E., et al. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105:184-8
10. Masur H., Tuazon C., Gill V., et al. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-mycobacterium intracellulare bacteremia in patients with AIDS. J Infect Dis 1987; 155:127-9
11. Agins B.D., Berman D.S., Spicehandler D., el Sadr W., Simberkoff M.S., Rahal J.J. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis 1989; 159:784-7
12. Hoy J., Mijch A., Sandland M., Grayson L., Lucas R., Dwyer B. Quadruple-drug therapy for Mycobacterium avium–intracellulare bacteremia in AIDS patients. J Infect Dis 1990; 161:801-5
13. Chiu J., Nussbaum J., Bozzette S., et al. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann Intern Med 1990; 113:358-61
14. Benson C., Pottage J., Kessler H. Treatment of AIDS-related disseminated Mycobacterium avium complex disease (D-MAC) with a multiple drug regimen including amikacin. In: Final program and abstracts of the Sixth International Conference on AIDS, San Francisco, June 20 and 21, 1990. Vol. 1. San Francisco: University of California, 1990: 251. abstract
15. Kemper C.A., Chiu J., Meng T.C., Nussbaum J., Bartok A.E., California Collaborative Treatment Group. Microbiologic and clinical response of patients with AIDS and MAC bacteremia to a four oral drug regimen. In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 21–24, 1990. Washington, D.C.: American Society for Microbiology, 1990: 297. abstract
16. Horsburgh C.R., Havlik J.A., Thompson S.E. Survival of AIDS patients with disseminated Mycobacterium avium complex infection (DMAC): a case–control study. In: Final program and abstracts of the Sixth International Conference on AIDS, San Francisco, June 20 and 21, 1990. Vol. 1. San Francisco: University of California, 1990: 251. abstract.
17. Bessesen M.T., Berry C.D., Johnson M.A., Klaus B., Blaser M.J., Ellison R.T. Site of origin of disseminated MAC infection in AIDS. In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 21–24, 1990. Washington, D.C.: American Society for Microbiology, 1990: 297. abstract
18. Wallace J.M., Hannah J.B. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. Chest 1988; 93:926-32
19. Metroka C. Prophylaxis for Pneumocystis carinii pneumonia and other opportunistic infections. AIDS Targeted Inf Newsl 1990; 4(6): 1-2.
20. Okello D.O., Sewankambo N., Goodgame R., et al. Absence of bacteremia with Mycobacterium avium–intracellulare in Ugandan patients with AIDS. J Infect Dis 1990; 162:208-10
21. Stine T.M., Harris A.A., Levin S., Rivera N., Kaplan R.L. A pseudoepidemic due to atypical mycobacteria in a hospital water supply. JAMA 1987; 258:809-11
22. du Moulin G.C., Stottmeier K.D., Pelletier P.A., Tsang A.Y., Hedley-Whyte J. Concentration of Mycobacterium avium by hospital hot water systems. JAMA 1988; 260:1599-601
23. Wendt S.L., George K.L., Parker B.C., Gruft H., Falkinham J.O. III. Epidemiology of infection by nontuberculous mycobacteria. III. Isolation of potentially pathogenic mycobacteria from aerosols. Am Rev Respir Dis 1980; 122:259-63
24. Graham L. Jr., Warren N.G., Tsang A.Y., Dalton H.P. Mycobacterium avium complex pseudobacteriuria from a hospital water supply. J Clin Microbiol 1988; 26:1034-6
25. Guthertz L.S., Damsker B., Bottone E.J., Ford E.G., Midura T.F., Janda J.M. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis 1989; 160:1037-41
26. Yakrus M.A., Good R.C. Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome. J Clin Microbiol 1990; 28:926-9
27. Hampson S.J., Portaels F., Thompson J., et al. DNA probes demonstrate a single highly conserved strain of mycobacterium avium infecting AIDS patients. Lancet 1989; 1:65-68
28. Crawford J.T., Bates J.H. Analysis of plasmids in Mycobacterium avium–intracellulare isolates from persons with acquired immunodeficiency syndrome. Am Rev Respir Dis 1986; 134:659-61
29. Gangadharam P.R.J., Perumal V.K., Crawford J.T., Bates J.H. Association of plasmids and virulence of Mycobacterium avium complex. Am Rev Respir Dis 1988; 137:212-4
30. Pethel M.L., Falkinham J.O. III. Plasmid-influenced changes in Mycobacterium avium catalase activity. Infect Immun 1989; 57:1714-8
31. Edwards L.B., Acquaviva F.A., Livesay V.T., Cross F.W., Palmer C.E. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969; 99:Suppl: 1-132
32. Wayne W.G., Young L.S., Bertram M. Absence of mycobacterial antibody in patients with acquired immune deficiency syndrome. Eur J Clin Microbiol 1986; 5:363-365
33. Winter S.M., Bernard E.M., Gold J.W.M., Armstrong D. Humoral response to disseminated infection by Mycobacterium avium-Mycobacterium intracellulare in acquired immunodeficiency syndrome and hairy cell leukemia. J Infect Dis 1985; 151:523-7
34. Farber C.-M., Yernault J.-C., Legros F., Debruyn J., Van Vooren J.-P. Detection of anti-p32 mycobacterial IgG antibodies in patients with AIDS. J Infect Dis 1990; 162:279-80
35. Perlman D.M., Ampel N.M., Schifman R.B., et al. Persistent Campylobacter jejuni infections in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1988; 108:540-6
36. Simberkoff M.S., El Sadr W., Schiffman G., Rahal J.J. Jr. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with a report of pneumococcal vaccine failure. Am Rev Respir Dis 1984; 130:1174-6
37. Mess T.P. Mycobacterium avium complex isolated from the lung only, does it disseminate? In: Proceedings of the Third International Conference on AIDS, Washington, D.C. June 1–5, 1987. Washington, D.C.: Department of Health and Human Services, 1987:146. abstract.
38. Berlin O.G.W., Ruane P.J., Drake T.A., Morgan M.A., Wolfe P.R., George W.L. Gastrointestinal infection with Mycobacterium avium complex (MAC), a possible precursor to dissemination in patients with ARC/AIDS. In: Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, October 4–7, 1987. Washington, D.C.: American Society for Microbiology, 1987: 242. abstract.
39. Horsburgh C.R., Metchock B.G., McGowan J.E., Thompson S.T. Progression to disseminated infection in HIV-infected persons colonized with mycobacteria other than tuberculosis. Am Rev Respir Dis 1991; 143: Suppl:A279. abstract
40. Edwards L.B., Palmer C.E. Isolation of “atypical” mycobacteria from healthy persons. Am Rev Respir Dis 1959; 80:747-749
41. Mills C.C. Occurrence of Mycobacterium other than Mycobacterium tuberculosis in the oral cavity and in sputum. Appl Microbiol 1972; 24:307-10
42. Graham D.Y., Markesich D.C., Yoshimura H.H. Mycobacteria and inflammatory bowel disease. Gastroenterology 1987; 92:436-42
43. Portaels F., Larsson L., Smeets P. Isolation of mycobacteria from healthy persons#x0027; stools. Int J Lepr Other Mycobact Dis 1988; 56:468-70
44. Tenholder M.F., Moser R.J. III, Tellis C.J. Mycobacteria other than tuberculosis: pulmonary involvement in patients with acquired immunodeficiency syndrome. Arch Intern Med 1988; 148:953-5
45. Ruf B., Schuermann D., Brehmer W., Pohle H.D. Pulmonary manifestations due to Mycobacterium avium-Mycobacterium intracellulare in AIDS patients. Am Rev Respir Dis 1990; 141:Suppl:A611. abstract
46. Gray J.R., Rabeneck L. Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol 1989; 84:1521-4
47. Wolke A., Meyers S., Adelsberg B.R., et al. Mycobacterium avium–intracellulareassociated colitis in a patient with the acquired immunodeficiency syndrome. J Clin Gastroenterol 1984; 6:225-9
48. Roth R.I., Owen R.L., Keren D.F., Volberding P.A. Intestinal infection with Mycobacterium avium in acquired immune deficiency syndrome (AIDS). Dig Dis Sci 1985; 30:497-504
49. Klatt E.C., Jensen D.F., Meyer P.R. Pathology of Mycobacterium avium–intracellulare infection in acquired immunodeficiency syndrome. Hum Pathol 1987; 18:709-14
50. Wong B., Edwards F.F., Kiehn T.E., et al. Continuous high-grade Mycobacterium avium–intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med 1985; 78:35-40
51. Toba H., Crawford J.T., Ellner J.J. Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon. Infect Immun 1989; 57:239-44
52. Douvas G.S., Looker D.L., Vatter A.E., Crowle A.J. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun 1985; 50:1-8
53. Bermudez L.E., Young L.S. Tumor necrosis factor, alone or in combination with IL–2, but not IFN-γ, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 1988; 140:3006-13
54. Bermudez. Recombinant granulocytemacrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex. J Leukoc Biol 1990; 48:67-73
55. Bermudez L.E.M., Kolonoski P., Young L.S. Natural killer cell activity and macrophage-dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model. J Leukoc Biol 1990; 47:135-141
56. Crowle A.J., Cohn D.L., Poche P. Defects in sera from acquired immunodeficiency syndrome (AIDS) patients and from non-AIDS patients with Mycobacterium avium infection which decrease macrophage resistance to M. avium. Infect Immun 1989; 57:1445-51
57. Packer S.J., Cesario T., Williams J.H. Jr. Mycobacterium avium complex infection presenting as endobronchial lesions in immunosuppressed patients. Ann Intern Med 1988; 109:389-93
58. Blumenthal D.R., Zucker J.R., Hawkins C.C. Mycobacterium avium complex-induced septic arthritis and osteomyelitis in a patient with the acquired immunodeficiency syndrome. Arthritis Rheum 1990; 33:757-8
59. Noel S.B., Ray M.C., Greer D.L. Cutaneous infection with Mycobacterium avium–intracellulare scrofulaceum intermediate: a new pathogenic entity. J Am Acad Dermatol 1988; 19:492-5
60. Cohen J.I., Saragas S.J. Endophthalmitis due to Mycobacterium avium in a patient with AIDS. Ann Ophthalmol 1990; 22:47-51
61. Havlik J.A., Horsburgh C.R., Metchock B., Williams P., Thompson S.E. Clinical risk factors for disseminated Mycobacterium avium complex infection (DMAC) in persons with HIV infection. In: Final program and abstracts of the Sixth International Conference on AIDS, San Francisco, June 20 and 21, 1990. Vol. 1. San Francisco: University of California, 1990: 250. abstract.
62. Yagupsky P., Menegus M.A. Cumulative positivity rates of multiple blood cultures for Mycobacterium avium–intracellulare and Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1990; 114:923-5
63. Heifets L. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs. Antimicrob Agents Chemother 1988; 32:1131-6
64. Heifets L.B., Iseman M.D. Choice of antimicrobial agents for M. avium disease based on quantitative tests of drug susceptibility. N Engl J Med 1990; 323:419-420
65. Inderlied C.B., Young L.S., Yamada J.K. Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods. Antimicrob Agents Chemother 1987; 31:1697-702
66. Baron E.J., Young L.S. Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium–intracellulare infections in patients with acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 1986; 5:215-220
67. Horsburgh C.R. Jr., Cohn D.L. Mycobacterium avium complex and the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105:968-9
68. Yajko D.M., Kirihara J., Sanders C., Nassos P., Hadley W.K. Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother 1988; 32:1392-5
69. Heifets L.B., Iseman M.D., Lindholm-Levy P.J. Combinations of rifampin or rifabutine plus ethambutol against Mycobacterium avium complex: bactericidal synergistic, and bacteriostatic additive or synergistic effects. Am Rev Respir Dis 1988; 137:711-5
70. Horsburgh C.R., Havlik J.A., Metchock B.G., Thompson S.E. Oral therapy of disseminated Mycobacterium avium complex infection in AIDS relieves symptoms and is well tolerated. Am Rev Respir Dis 1991; 143:Suppl:A115. abstract.
71. Inderlied C.B., Kolonoski P.T., Wu M., Young L.S. In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex. J Infect Dis 1989; 159:994-7
72. Erratum, J Infect Dis 1989; 160:1095.
73. Naik S., Ruck R. In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. Antimicrob Agents, Chemother 1989; 33:1614-6
74. Dautzenburg B., Legris S., Truffot C., Grosset J. Double blind study of efficacy of clarithromycin versus placebo in Mycobacterium avium intracellulare infection in AIDS patients. Am Rev Respir Dis 1990; 141:A615. abstract
75. Bermudez L.E., Yau-Young A.O., Lin J.P., Cogger J., Young L.S. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. J Infect Dis 1990; 161:1262-1268